Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

April 19, 2024

Study Completion Date

April 19, 2024

Conditions
Retinitis Pigmentosa
Trial Locations (8)

15213

UPMC Eye Centre, Pittsburgh

30322

Emory Eye Centre, Atlanta

48105

Kellogg Eye Center, Ann Arbor

92093

Shiley Eye Institute - UCSD, La Jolla

94303

Stanford University, Spencer Center for Vision Research, Stanford

02114

Massachusetts Eye and Ear Infirmary, Boston

M5G 0A4

The Hospital for Sick Children, Toronto

EC1V 2PD

Moorfields Eye Hospital, London

All Listed Sponsors
collaborator

Janssen, LP

INDUSTRY

lead

MeiraGTx UK II Ltd

INDUSTRY

NCT03349242 - Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR) | Biotech Hunter | Biotech Hunter